Loading clinical trials...
Loading clinical trials...
Cladribine Tablets: Observational Evaluation of Effectiveness and PROs in Suboptimally Controlled Patients Previously Taking Injectable DMDs for RMS (CLICK-MS)
Conditions
Interventions
Cladribine
Locations
18
United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
HCA Research Institute
Englewood, Colorado, United States
Advanced Neurosciences Research
Fort Collins, Colorado, United States
Prairie Education & Research
Springfield, Illinois, United States
Fort Wayne Neurological Center
Fort Wayne, Indiana, United States
College Park Family Care Center
Overland Park, Kansas, United States
Start Date
May 21, 2019
Primary Completion Date
March 30, 2024
Completion Date
March 30, 2024
Last Updated
April 29, 2025
NCT07325292
NCT05748015
NCT04876339
NCT05344469
NCT07489794
NCT07225504
Lead Sponsor
EMD Serono Research & Development Institute, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions